October 15, 2026

MRI vs Biopsy for Prostate Cancer: What Is the Difference?

A guide to the differences between prostate MRI scans and biopsies, explaining how each test works, when they are needed and how they help diagnose prostate cancer.

Wave Blue

If you are being investigated for prostate cancer, you may be offered an MRI scan, a prostate biopsy or both. Understandably, this can raise questions about what each test involves, how they differ and whether you need both.

Although MRI scans and biopsies are both used to investigate prostate cancer, they serve different purposes. An MRI provides detailed images of the prostate to help identify areas that may be suspicious, while a biopsy involves taking small tissue samples to check for cancer cells.

So, how do MRI and biopsy compare, and what happens if your MRI results are normal?

What is a prostate MRI scan?

A prostate MRI is an imaging test that uses magnetic fields and radio waves to produce detailed pictures of the prostate gland and surrounding tissues.

A multiparametric MRI (mpMRI) combines different types of imaging to help identify areas that may contain clinically significant prostate cancer.

The scan can help a specialist assess the size and location of suspicious areas, understand how likely they are to contain significant cancer and determine whether a biopsy may be needed.

MRI is non-invasive, meaning it does not involve needles or taking tissue samples. During the scan, you lie inside an MRI scanner while images of the prostate are taken.

An MRI can provide valuable information, but it cannot confirm prostate cancer on its own. Some cancers may not be visible on a scan, which is why further investigation may sometimes be recommended.

What is a prostate biopsy?

A prostate biopsy involves taking small samples of tissue from the prostate using a thin needle. These samples are then examined under a microscope by a specialist to look for cancer cells.

A biopsy can help confirm whether prostate cancer is present and provide information about how aggressive the cancer appears to be. This information helps doctors assess the risk posed by the cancer and discuss suitable treatment options.

There are different ways to perform a prostate biopsy, including transperineal biopsy, where the needle passes through the skin between the scrotum and anus, and transrectal biopsy, where the needle passes through the rectal wall.

The approach used will depend on the individual's circumstances and the clinical team's recommendations.

Unlike an MRI scan, a biopsy is an invasive procedure. It can cause some discomfort and with more invasive procedures there can be a risk of complications, including bleeding and infection. Your specialist should explain what the procedure involves, how to prepare and what to expect afterwards.

MRI vs biopsy: the key differences

Prostate MRI Prostate biopsy
Main purpose Identifies suspicious areas in the prostate Checks tissue samples for cancer cells
How it works Uses magnetic fields and radio waves to create detailed images Uses a needle to collect small tissue samples
Confirms cancer? No, it assesses the likelihood of cancer Can confirm cancer by examining tissue
Invasiveness Non-invasive Invasive
Discomfort Usually painless, although lying still can be uncomfortable May cause discomfort during and after the procedure
Risks No radiation exposure; some people cannot have MRI because of certain implants or other factors Includes risks such as bleeding, infection and urinary difficulties
Role in diagnosis Helps identify suspicious areas and guide further investigation Helps establish the diagnosis and assess how aggressive the cancer may be

MRI and biopsy are complementary tests rather than alternatives that do exactly the same thing. MRI helps identify where a problem may be, while biopsy provides tissue that can be examined to determine whether cancer is present.

Is an MRI or biopsy better at detecting prostate cancer?

MRI and biopsy provide different types of information, so one cannot simply replace the other in every situation.

An MRI can identify suspicious areas that might otherwise be missed by a biopsy that samples the prostate without using imaging to guide it. It can also help specialists target suspicious areas more accurately when taking tissue samples.

However, an MRI cannot detect every prostate cancer. Some smaller or less visible cancers may not show up clearly on a scan.

A biopsy provides more direct evidence by allowing tissue to be examined under a microscope. However, because only small samples are taken from the prostate, a biopsy can sometimes miss cancer or underestimate how aggressive it is.

Using MRI findings alongside biopsy results, PSA levels and other clinical information helps specialists build a more complete picture of the individual's cancer risk.

Do you need a biopsy if your MRI is normal?

This is a common question for men undergoing investigations for prostate cancer.

A normal or low-risk MRI result is reassuring, as it suggests that there are no obvious suspicious areas on the scan. However, it does not completely rule out prostate cancer.

Whether a biopsy is needed after a normal MRI depends on several factors, including your PSA level, PSA density, family history, examination findings and any previous biopsy results.

For some men, it may be reasonable to monitor PSA levels rather than proceed immediately to a biopsy. For others, further investigation may still be recommended if there is a strong suspicion of cancer.

The decision should be made with your specialist after discussing the potential benefits and risks of further testing. A normal MRI should not automatically be taken as proof that cancer is absent.

Does an MRI happen before a prostate biopsy?

In most cases, yes. Current UK guidance recommends offering a multiparametric MRI as the first investigation for men with suspected localised prostate cancer who are suitable for radical treatment.

The MRI results help determine whether a biopsy is needed and, if so, which areas of the prostate should be sampled.

If the scan identifies a suspicious area, an MRI-informed biopsy can be used to target that area. Depending on the findings, the specialist may also recommend taking additional samples from other parts of the prostate.

This approach helps improve the detection of clinically significant prostate cancer and can reduce unnecessary biopsies in some men.

However, the exact diagnostic pathway will depend on the MRI findings, PSA results and individual risk factors.

Can an MRI or biopsy miss aggressive prostate cancer?

Neither test is perfect.

An MRI may not identify every cancer, while a biopsy samples only a small proportion of the prostate. As a result, some cancers may be missed or their aggressiveness may initially be underestimated.

For example, a biopsy may suggest that a cancer is low risk, but further assessment or examination of a larger amount of tissue may reveal a more aggressive disease than first thought.

If MRI findings, biopsy results and PSA levels do not agree, your specialist may recommend further assessment, closer monitoring or another biopsy.

This is why results need to be interpreted together rather than relying on one test in isolation.

What happens after an MRI or prostate biopsy?

The next steps depend on the results and your overall risk of prostate cancer.

If an MRI does not show suspicious areas and your overall risk is low, your specialist may recommend monitoring your PSA levels and arranging further investigations if needed.

If an MRI identifies a suspicious area, a biopsy may be recommended to establish whether cancer is present.

If a biopsy confirms prostate cancer, the results can help determine the grade and risk category of the disease. Your specialist can then discuss appropriate options, which may include active surveillance, surgery, radiotherapy or other treatments depending on the type and extent of the cancer.

If the MRI and biopsy results are inconclusive or do not match the wider clinical picture, further investigations may be necessary.

MRI vs biopsy: which test is right for me?

MRI and biopsy play different but complementary roles in investigating prostate cancer. An MRI helps identify suspicious areas, while a biopsy can confirm the presence of cancer and provide important information about its aggressiveness.

For many men, MRI is the first step, with a biopsy recommended if the scan findings or other risk factors suggest further investigation is needed. However, a normal MRI does not always mean that a biopsy can be avoided.

The most appropriate approach will depend on your PSA results, MRI findings, medical history and individual risk factors.

Discussing these factors with a urologist can help you understand your results, whether further tests are needed and what the next steps may be.

Prostate cancer investigations with Dr Edward Calleja

Dr Edward Calleja is a Urology consultant and surgeon specialising in prostate cancer diagnosis and treatment.

If you have a raised PSA, have been advised to undergo further investigations or are concerned about your MRI or biopsy results, a consultation can provide an opportunity to discuss your circumstances and the next steps in your assessment.

Understanding what each test can and cannot tell you is an important part of making informed decisions about your prostate health.

Book a consultaion with Dr Edward Calleja.